GEN Exclusives

More »

GEN News Highlights

More »
Dec 13, 2013

Little C. elegans May Hold Key to Human Life Extension

Little C. elegans May Hold Key to Human Life Extension

Source: National Human Genome Research Institute

  • Scientists at the Buck Institute say they have combined mutations in two pathways well known for lifespan extension and found a synergistic five-fold extension of longevity in the nematode C. elegans. The research (“Germline Signaling Mediates the Synergistically Prolonged Longevity by Double Mutations in daf-2 and rsks-1 in C. elegans”), which appears online in Cell Reports, introduces the possibility of combination therapy for aging and the maladies associated with it.

    The mutations inhibited key molecules involved in insulin signaling (IIS) and the nutrient signaling pathway Target of Rapamycin (TOR). Lead scientist Pankaj Kapahi, Ph.D., said single mutations in TOR (in this case rsks-1) usually result in a 30% lifespan extension, while mutations in IIS (Daf-2) often result in a doubling of lifespan in the worms, when added together, would be expected to extend longevity by 130%.

    “Instead, what we have here is a synergistic five-fold increase in lifespan,” continued Dr. Kapahi. “The two mutations set off a positive feedback loop in specific tissues that amplified lifespan. Basically these worms lived to the human equivalent of 400 to 500 years.”

    “Our findings highlight the importance of the germline in the significantly increased longevity produced by daf-2 rsks-1, which has important implications for interactions between the two major conserved longevity pathways in more complex organisms,” wrote the investigators.

    Dr. Kapahi added that the research points to the possibility of using combination therapies for aging, similar to what is done for cancer and HIV.

    “In the early years, cancer researchers focused on mutations in single genes, but then it became apparent that different mutations in a class of genes were driving the disease process,” he explained. “The same thing is likely happening in aging.”

    Dr. Kapahi believes this research could help explain why scientists are having a difficult time identifying single genes responsible for the long lives experienced by human centenarians. “It's quite probable that interactions between genes are critical in those fortunate enough to live very long, healthy lives,” he noted.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?